Cancer site | French mortality data | Simulation #1: independence | Simulation #2: RR from Fang et al. [4] | Fang et al. study[4] | Collider biasb | Reporting biasc | |||
---|---|---|---|---|---|---|---|---|---|
OR | [95% CI] | OR | [95% CI] | OR | [95% CI] | RR | |||
No cancera | 1.00 | 1.00 | 1.00 | 1.0 | 1.0 | 1.0 | |||
Prostate | 0.24 | [0.22;0.26] | 0.71 | [0.68;0.75] | 1.14 | [1.10;1.18] | 1.9 | 1.7 | 4.7 |
Cutaneous melanoma | 0.01 | [0.01;0.02] | 0.61 | [0.53;0.70] | 0.77 | [0.68;0.86] | 1.4 | 1.8 | 64 |
Breast | 0.04 | [0.03;0.04] | 0.58 | [0.52;0.64] | 0.85 | [0.78;0.92] | 1.6 | 1.9 | 24 |
Colorectal | 0.05 | [0.05;0.06] | 0.35 | [0.33;0.37] | 0.50 | [0.48;0.52] | 1.6 | 3.2 | 9.4 |
Oesophageal, liver, pancreatic | 0.03 | [0.03;0.03] | 0.17 | [0.16;0.19] | 0.55 | [0.53;0.58] | 4.5 | 8.1 | 20 |
Lung | 0.02 | [0.02;0.02] | 0.14 | [0.13;0.15] | 0.36 | [0.35;0.38] | 3.3 | 9.1 | 17 |
Central nervous system | 0.01 | [0.01;0.01] | 0.11 | [0.09;0.14] | 0.25 | [0.22;0.28] | 2.3 | 9.3 | 35 |